Multiple Sclerosis and Related DisordersVolume 42, July 2020, 102201CorrespondenceBenign course of COVID-19 in a multiple sclerosis patient treated with OcrelizumabAuthor links open overlay panelKulachanya Suwanwongse, Nehad ShabarekShow moreShareCitehttps://doi.org/10.1016/j.msard.2020.102201Get rights and contentPrevious article in issueNext article in issueRecommended articlesCited by (0)View AbstractPublished by Elsevier B.V.